Health Links
Stanford Medicine: COVID-19 Vaccine Effective in People Wth Cancer
The Moderna and Pfizer BioNTech vaccines prevented COVID-19 infection in cancer patients, particularly in those whose treatment concluded more than six months before vaccination, say researchers at Stanford, Harvard and the VA. The mRNA-based COVID-19 vaccines are effective at preventing infection in most cancer patients, according to a nationwide study of veterans diagnosed with cancer in the past decade. But the researchers found that some vaccinated patients, including those who had received therapies that suppressed their immune systems within the six months before vaccination, were less protected than their peers from COVID-19 infection for the duration of the study.
more »
The Stanford Center on Longevity: The New Map of Life
"In the United States, as many as half of today’s 5-year-olds can expect to live to the age of 100, and this once unattainable milestone may become the norm for newborns by 2050. Yet, the social institutions, norms and policies that await these future centenarians evolved when lives were only half as long and need updating. In 2018, The Stanford Center on Longevity launched an initiative called The New Map of Life, believing that one of the most profound transformations of the human experience calls for equally momentous and creative changes in the ways we lead these 100-year lives, at every stage." more »
Kaiser Health News: Why You Can’t Find Cheap At-Home Covid Tests
"While developing a rapid test that detects the coronavirus in someone’s saliva, Blink Science, a Florida-based startup, heard something startling: The Food and Drug Administration had more than 3,000 emergency use authorization applications and didn’t have the resources to get through them." "The U.S. produced covid-19 vaccines in record time, but, nearly two years into the pandemic, consumers have few options for cheap tests that quickly screen for infection, though they are widely available in Europe. Experts say the paucity of tests and their high prices undermine efforts in the U.S. to return to normal life. more »
GAO: Vaccine Development: Capabilities and Challenges for Addressing Infectious Diseases
Policymakers could provide support for public-private partnerships to strategically address potential pandemic pathogens identified as priorities. These partnerships could, for example, develop and test vaccine candidates that may provide protection from pathogens with pandemic potential. This early development could provide a coordinated foundation that can be mobilized in an emergency. Such an approach could speed vaccine development as well as potentially reduce risk for vaccine researchers and developers concerning questions of safety, efficacy, and manufacturability. The lack of certainty of the commercial market and government funding for vaccines against pathogens with pandemic potential may be too risky for the private sector to undertake. more »